- Home
- ASPS vs UBX Comparison
ASPS vs UBX Comparison
Compare ASPS & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- UBX
- Stock Information
- Founded
- ASPS 1999
- UBX 2009
- Country
- ASPS Luxembourg
- UBX United States
- Employees
- ASPS N/A
- UBX N/A
- Industry
- ASPS Other Consumer Services
- UBX Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- UBX Health Care
- Exchange
- ASPS Nasdaq
- UBX Nasdaq
- Market Cap
- ASPS 29.3M
- UBX 24.6M
- IPO Year
- ASPS N/A
- UBX 2018
- Fundamental
- Price
- ASPS $0.85
- UBX $1.26
- Analyst Decision
- ASPS
- UBX Strong Buy
- Analyst Count
- ASPS 0
- UBX 3
- Target Price
- ASPS N/A
- UBX $9.00
- AVG Volume (30 Days)
- ASPS 172.2K
- UBX 70.7K
- Earning Date
- ASPS 10-24-2024
- UBX 11-04-2024
- Dividend Yield
- ASPS N/A
- UBX N/A
- EPS Growth
- ASPS N/A
- UBX N/A
- EPS
- ASPS N/A
- UBX N/A
- Revenue
- ASPS $153,278,000.00
- UBX N/A
- Revenue This Year
- ASPS $15.33
- UBX N/A
- Revenue Next Year
- ASPS $32.37
- UBX N/A
- P/E Ratio
- ASPS N/A
- UBX N/A
- Revenue Growth
- ASPS 5.19
- UBX N/A
- 52 Week Low
- ASPS $0.70
- UBX $1.11
- 52 Week High
- ASPS $4.60
- UBX $2.26
- Technical
- Relative Strength Index (RSI)
- ASPS 36.24
- UBX 47.73
- Support Level
- ASPS $0.70
- UBX $1.11
- Resistance Level
- ASPS $1.27
- UBX $1.37
- Average True Range (ATR)
- ASPS 0.12
- UBX 0.08
- MACD
- ASPS -0.04
- UBX 0.00
- Stochastic Oscillator
- ASPS 23.95
- UBX 69.49
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.